Times Square Capital Management, LLC Guardant Health, Inc. Transaction History

Times Square Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$25.44 - $59.78 $656,352 - $1.54 Million	-25,800 Reduced 75.44%	8,400 $228,000
Q3 2022 Nov 09, 2022	SELL	$43.66 - $61.0 $654,900 - $915,000	-15,000 Reduced 30.49%	34,200 $1.84 Million
Q2 2022 Aug 05, 2022	SELL	$28.82 - $77.35 $8.77 Million - $23.5 Million	-304,300 Reduced 86.08%	49,200 $1.99 Million
Q4 2021 Feb 04, 2022	SELL	$88.71 - $120.43 $3.2 Million - $4.35 Million	-36,100 Reduced 9.27%	353,500 $35.4 Million
Q3 2021 Nov 08, 2021	BUY	$98.77 - $132.17 $8.83 Million - $11.8 Million	89,450 Added 29.8%	389,600 $48.7 Million
Q2 2021 Aug 09, 2021	BUY	$109.77 - $165.68 $3.83 Million - $5.79 Million	34,925 Added 13.17%	300,150 $37.3 Million
Q1 2021 May 12, 2021	BUY	$127.04 - $179.1 $7.42 Million - $10.5 Million	58,425 Added 28.25%	265,225 $40.5 Million
Q4 2020 Feb 12, 2021	BUY	$99.96 - $135.93 $20.7 Million - $28.1 Million	206,800 New	206,800 $26.7 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.